MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration with Genomics England to study PacBio’s technology for identifying genetic variants in unexplained rare disease cases. Genomics England was initially created to deliver the 100,000 Genomes Project – the largest whole genome sequencing disease cohort of cancer and […]
La Vista, NE –Streck is pleased to announce the partnership with Ceres Nanosciences to distribute Nanotrap® Magnetic Virus Particles that provide rapid viral concentration directly from raw sewage. This product dramatically reduces the time and effort required to test wastewater samples for COVID-19 surveillance. Wastewater surveillance can act as an early-warning system for COVID-19 “hotspots” within […]
Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Since study launch, 12 sites across 5 countries have already signed up for participation BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS SA (Nasdaq: SOPH), the […]
Houston, TX – AlpHa Measurement Solutions LLC (“AlpHa”), a leader in the liquid sensing technology space, today announced the acquisition of Champaign, Illinois-based ANDalyze. Terms of the deal were not disclosed. With a record of strong organic and inorganic growth since its formation, AlpHa Measurement Solutions adds ANDalyze’s innovative DNA-enzyme-based sensors used to detect trace […]
New York and Cambridge, MA — Gencove, a pioneer of low-pass whole genome sequencing (LPWGS) analysis, and BGI Americas Corporation, US subsidiary of BGI Genomics Co. Ltd. (300676.SZ), one of the world’s leading multi-omics companies, today announced the extension of the subscription and joint marketing agreements. The partnership combines BGI’s sequencing services from proprietary DNBSEQ™ […]
Pfizer and Codex DNA agree to strategic, multiyear, early access research collaboration, leveraging Codex DNA’s novel enzymatic DNA synthesis (EDS) technology Pfizer’s successful development and commercialization of licensed products could result in milestone payments in excess of $100 million SAN DIEGO — Codex DNA, Inc. (NASDAQ: DNAY), a leader in the development of automated solutions […]
NASHVILLE, Tenn. — Today, Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), announced an agreement with Illumina, a leading genomic technology company, to realize the full potential of VUMC’s DNA databank, BioVU®. The agreement is a continuation of Vanderbilt’s long-term effort around BioVU and will accelerate genomic sequencing, resulting in new discoveries to advance […]
Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing and to bring improved insights to patients with breast cancer globally SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for […]
Collaboration will transform new insights into drug discovery and therapy development through large-scale genomics SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using […]
SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer. The partnership spans current and future CDx programs, with plans […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
